Tom Graney, an experienced financial executive, has joined the board of Mogrify Ltd as a non-executive director to help oversee the company’s cellular reprogramming and delivery technologies. He is currently chief executive and chief financial officer of Oxurion NV, an ophthalmology company. Previously he was CFO at Generation Bio Co, Vertex Pharmaceuticals Inc, and Ironwood Pharmaceuticals Inc. Prior to this, he worked for more than 10 years at Johnson & Johnson Inc and its affiliates.
Mogrify announced the appointment on 2 November 2021.
Copyright 2021 Evernow Publishing Ltd